Reversing The World's Fastest Spreading Disease

TL;DR

Using bacteria to stop mosquitoes from spreading dengue.

Transcript

For half of the planet, mosquitoes are more than just a nuisance. Their bites transmit parasites and viruses that kill millions of people each year. One of them, dengue virus, causes dengue fever. It's often called breakbone fever because the patients feel like the bones in their bodies are being broken. If you get sick with dengue, you can have ... Read More

Key Insights

• Dengue fever, also known as breakbone fever, is a rapidly spreading tropical disease transmitted by mosquitoes, affecting billions globally, with symptoms ranging from mild to severe, including internal bleeding and shock.
• The Aedes aegypti mosquito, responsible for spreading diseases like dengue, yellow fever, and Zika, thrives in urban environments, making eradication efforts challenging due to its adaptability and breeding habits.
• Traditional methods focusing on mosquito eradication have proven ineffective, leading to the exploration of innovative solutions like the use of Wolbachia bacteria to inhibit virus transmission in mosquitoes.
• Wolbachia is a naturally occurring bacterium present in many insect species, but not in Aedes aegypti. Introducing it to these mosquitoes stops them from transmitting viruses like dengue and Zika.
• The World Mosquito Program, led by Scott O’Neill, is pioneering the use of Wolbachia-infected mosquitoes, with trials showing significant reductions in dengue cases in areas like Yogyakarta, Indonesia.
• The Wolbachia method involves injecting mosquito eggs with the bacterium, allowing it to spread naturally through mosquito populations, ultimately reducing disease transmission without harming the mosquitoes.
• Community involvement and understanding are crucial for the success of the Wolbachia project, as releasing bacteria-infected mosquitoes challenges long-held beliefs about mosquito eradication.
• The program aims to cover 100 million people by 2023, requiring substantial funding and global cooperation to address the monumental task of reducing the risk of mosquito-borne diseases for billions.

Questions & Answers

Q: What makes dengue fever particularly dangerous?

Dengue fever, often referred to as breakbone fever, is dangerous due to its wide range of symptoms, from mild discomfort to severe conditions like internal bleeding, shock, and even death. The disease is rapidly spreading, with billions at risk, and the symptoms can worsen with subsequent infections, increasing the risk of severe illness and mortality.

Q: Why is the Aedes aegypti mosquito difficult to eradicate?

The Aedes aegypti mosquito is challenging to eradicate because it thrives in urban environments, living alongside humans in cities and concrete jungles. It breeds in small water collections, making it difficult to eliminate all breeding sites. Additionally, its adaptability and ability to bite multiple times a day contribute to its persistence and the spread of diseases like dengue.

Q: How does Wolbachia bacteria help in controlling mosquito-borne diseases?

Wolbachia bacteria, when introduced to Aedes aegypti mosquitoes, prevents them from transmitting viruses like dengue, Zika, and yellow fever. The bacteria spread naturally through mosquito populations, as infected females pass it to their offspring. This biological intervention reduces disease transmission without killing the mosquitoes, offering a sustainable solution to controlling mosquito-borne diseases.

Q: What role does community involvement play in the Wolbachia project?

Community involvement is crucial for the Wolbachia project's success, as it requires public understanding and acceptance of releasing bacteria-infected mosquitoes. Educating communities about the project's goals and involving them in mosquito releases helps overcome skepticism and opposition, ensuring cooperation and support for the initiative's long-term success in reducing dengue transmission.

Q: What are the challenges faced in implementing the Wolbachia method globally?

Implementing the Wolbachia method globally faces challenges such as securing substantial funding, coordinating efforts across governments, and overcoming public skepticism. The scale of the task is monumental, requiring a sustained commitment to reach billions at risk of mosquito-borne diseases. Additionally, logistical challenges in breeding and releasing Wolbachia-infected mosquitoes need to be addressed for widespread adoption.

Q: What results have been observed from the Wolbachia trials in Yogyakarta?

The Wolbachia trials in Yogyakarta have shown promising results, with around a 70% reduction in dengue cases in areas where Wolbachia-infected mosquitoes were released. This significant decrease demonstrates the potential of the Wolbachia method in controlling dengue transmission. However, the mobility of people in the area suggests that the actual impact might be even greater than current estimates.

Q: How does Wolbachia spread within mosquito populations?

Wolbachia spreads within mosquito populations through vertical transmission, where infected females pass the bacteria to their offspring. If a Wolbachia-infected male mates with an uninfected female, her eggs will not hatch, favoring the spread of the bacteria. This natural transmission ensures that Wolbachia becomes prevalent in mosquito populations over time, reducing their ability to transmit viruses.

Q: What are the future goals of the World Mosquito Program regarding Wolbachia?

The World Mosquito Program aims to expand the Wolbachia method to cover 100 million people by 2023, addressing the risk posed by mosquito-borne diseases to billions globally. The program seeks to establish Wolbachia in mosquito populations worldwide, requiring significant funding and international cooperation to achieve a substantial reduction in diseases like dengue, ultimately aiming for their eradication.

Summary & Key Takeaways

• Dengue fever is the fastest spreading tropical disease, primarily transmitted by the Aedes aegypti mosquito, affecting billions globally. Traditional mosquito eradication methods have been ineffective, prompting innovative approaches like using Wolbachia bacteria to inhibit virus transmission.

• The World Mosquito Program, led by Scott O’Neill, is pioneering the use of Wolbachia-infected mosquitoes in places like Yogyakarta, Indonesia. The initiative has shown promising results, with significant reductions in dengue cases, proving the potential of this biological intervention.

• Community involvement is essential for the success of the Wolbachia project, as it challenges traditional beliefs about mosquito eradication. The program aims to cover 100 million people by 2023, requiring global cooperation and substantial funding to mitigate the risk of mosquito-borne diseases.